23.10.2017
- In a deal that could lead to the development of five new cancer vaccines, US drugs giant Eli Lilly is investing in German biopharma CureVac. Lilly will make an equity investment of...
27.09.2017
- Pharmaceutical companies are experiencing numerous challenges such as increasing cost pressures, declining autonomy or protocol-driven care. The reaction has to go beyond...
18.09.2017
- An older version of a thyroid drug made by Merck Serono is planned to be reintroduced in France after more than 9,000 of the country's three million users complained of serious...
14.09.2017
- US drugmaker Merck has announced plans to acquire Germany-based Rigontec, regarded as a pioneer in accessing the retinoic acid-inducible gene I (RIG-I) pathway as a novel and...
05.09.2017
- The European Parliament (EP) has approved new rules to protect workers from carcinogens and mutagens in the workplace, with the aim of saving up to 100,000 lives over the next 50...
04.09.2017
- US drugmaker Gilead Sciences has agreed to pay almost $12 billion to acquire compatriot Kite Pharma. Through the cash transaction, it will gain access to Car-T, Kite’s cutting-edge...
01.08.2017
- AstraZeneca has entered into a global collaboration with US drugmaker Merck to develop and commercialize the former’s investigational cancer treatments Lynparza (olaparib) and...
27.07.2017
- US pharmaceutical company Celgene has agreed to pay $280 million to settle a whistleblower lawsuit accusing it of fraud for promoting a thalidomide-based drug pair re-purposed to...
